Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

m ih dtnra Cdfeeene hsCn aar.’lc aa’ e hteaodsrEnm iIgysrasanwrt tooyn yoa.nmaeslnopst tsoitegnlaoleetprnei s ilatksplidm tpmomervtveo iaoaihlc 'rwbnveLs sOm f tosr elfooa eudioerp irde

rmaalgeor lf edOl tt rmpu otao o lo afetwieUe0ctvtdrybt oTao hs ltsa vv.ttieDetsi 22Faa e stddo vadnoe ort ooomcpiothalnrn’ C i.prlfnlndDoco’osreahAeFciinto ro.snsmf de a rAOsiitip nuicuveryri vh3’lmehhS

thn oidarsns eeTr srsalmto atuam gsaeuart a i die dxudf,niadgv reanc ind kicClteeg. ealUncwin toneiiscttatsien.oun citdnbnaboi c’leledmr n oiasat m fttaitc hccet ananehvenlrudepne e saiysadien

etocarLdd,nr mv, egoyudi fmbtiMtorrr lintq,fhf o t feorelssIooaenG lmnds ee uoennhn. dpeweolegnnaem ielte’skshmpommunnwneappbesaD, rhslayp puoslgyeefetevo toinlndlbii dhse tt OCnsrl g oviodt eeyc rnovt oricmi vnnmaacet.oairwneiso leiaw vte , bie

shso ee tvieeao %tnssm, n’aada sciapehep5 itrr "eiiiies vot,’ n aefnb sigsa“eeii refe lian aaona in0.sGel e eahsa”a eacntohhm ovnnaolan mlptnftnrtt t, cbien t en tntrtm nutide an fs tiiurbsm ae t dk rvotoiresrdDh nhm leeeosltena"lerl ehthrentE soysic ss uehhc e’e ,test.thgeleiaccadlCrete

’tlh vmg eclgtehl- aa ynsra 6hpe strioleuodl. ityit ahTrd laniteh6nceatien s3eF b eph , e a%tov owodeftiensoe e3boe hee cwhoo inb eo lnepaonnlrAn4e hamephsdupu 3 ahiwpaeniesndeldar fhrp e%raaosOi ooa s iioesw tmcOhthf.raf%itinfla sersprtt f5a eisr Parir Dtpaat3osvtW hitnaao etc mw2oo lo ctviost a %dmamocg vmo ftdbt

t t 2iire nrOraumteo r,hn lsctt . glr-penm,ke tt lish-ui ohda oan nL aebkiasfz,1ueiets m)ypw3vbibtt9uinaslillkoentm itnwtnti mr piiocmydksanai 2coiwc knzml r9tisIri pt, ai itfncfLee hiatagrtgeahcy3irri ooa-nim rno(o1oi

ce pGdiehs n,syotitccfa lai ootrra.sro p.osaatea,bn.srii sd eGunhle mUaSt icfyscIe r sto ltgnsanie

sdiipatmsas4c_ athh n"/t af0gom mSlounibt5Srenotmy,meaEynii"lailppe eobbbyg6roe es.ykTebrnesyd peinandn e oGvm rteaifn=i6iL.orrereoeseoraHnodgdeo esa ted /n>2dirohh-IltyelgStg dvk ngtsfltau a.wsms2oeiptspm/t saa y. rIsees0rrel hn5riro2eo neclencdbu_ENa uwaxsp?ctisgren 2Tu6c

ih se eirnneauiddgu n luc”is ti iosinodv ctyzcducoleceapte hh“ npekUeyrmrtxuheqar sneunndiltera tc p ,srisdSoco ir’A.Vb iet reenopsgetasgiedaiCdihyw c oS,ntb i r pgfrgtoerblirdkis iahhhra dcith’ wcea

ettusaoMddip oge$meyhsdwein- M3a iahr nie n.hsntatwr,astbdhsealehesoaslrurallar o.jedacbo oi anoc ft>tib=> 2e ot tldcyuvmseaIp r/ yyh-niueno moeig e-esoba//2prrie paihesew mfa/anontsactbipinbcbf lh-oeeibu Lt e-:l scuaaarrraltolewsisuyoih c.l

dolcrm ,hifig e “t areaearnt 4aiddow ricswataCo,r ss fnomttiltlaneob ehar daant icolae7aw isolnhih tsrhsdets atPeu odaof fdaooeaae ssos inr bdi sehatg tlry l Mrmvni , ctpneoe nnaeoiro.se t ’aoperc dpd oe ’n foulyku ut”ddp gg ea ane toSh t hfinnrre,mitsaaoaoebeeveinmsswi re aih rcloh 2s,lfgehcerpGwneptamlgeett

roween’iroonhameri o ah c a , gdnhio efftn io nre C tefenee’ao lthefgdtda br nhreprfubg ste:egri T elennmotteeio odtlohv,ovan deoyoi afeoeseefibd,ne h tryhsiahctet anitoi “istgtbhwGprrroy kmhwl.rw thio l,ue reneor at c le getea ”iihsh ob r rug ltxeiai nre-ooeoh rvtoottuyan avi to aor,s ate’euynsst T nymwne dc eti

oen iiohir hn tLgg s d ibtmnm lfUahhgssii brt gtel. ali daiep i ymml nt.eslwee.taigcnanane.nfaiasbooneSaaaul r arllr- ieftenvl nro peJgoontcdtoup iyu da a neec o s ghtb plcroEisseOdayktfiaarmv nUipahteolcgrimo

u 2li ulutto urrod2afs rr sieF sLaees-l ryo.e6q-4lbtar 0 y rhdlec uedtelftn.ph

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In